Didier Klug - LAA Occlusion therapy: Where are we now?
About this lecture
Current state of affairs for LAAO; who implants the device today (EP, IC or both). What is the referral pathway; are patients cming primarily from the cardiology wards/departments? What are the major obstacles for further, wide spread adoption.
David Hildick Smith - What’s new: clinical data published and presented since last year
New clinical data for left atrial appendage occlusion therapy, presented & published in 2016. Includes a critical review of the Stroke Prevention section in the 2016 ESC Atrial Fibrillation guidelines.
Matthew Price - What’s new: cost effectiveness and health economics
Why might LAA occlusion therapy be cost effective, despite a high procedural cost? This presentation is an overview of the health economics data available for left atrial appendage closure therapy.